BRCA1 and breast cancer: Moreover, Wong et al. identified 47.8% of pathogenic variants in non-BRCA1/2 genes among 220 HBOC patients in Singapore [44], and a mutation rate of 6% was observed for non-BRCA1/2 genes based on a 15-gene panel in a Malaysian BC patient study [45].